课题基金 / 基金详情

Center for Biophysical Assessment and Risk Management Following Irradiation

Center for Biophysical Assessment and Risk Management Following Irradiation
辐照后生物物理评估和风险管理中心
批准号:
7922898
负责人:
PAUL OKUNIEFF
金额:
$30.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-22 至 2011-08-31

项目摘要

项目成果

PAUL OKUNIEFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The central theme of our Center is the continued improvement of existing approaches for predicting risk and for ameliorating the side effects of radiation. Our risk and intervention estimators will be based on physical dose, host cytokine balance, and genotoxicity. We will emphasize understanding and mitigating radiationrelated inflammation. In the Center, we direct attention to different aspects of radiation terrorism, but emphasize damage to solid organs at exposures that are not immediately lethal (e.g. low dose chronic exposures, inhalational exposure). We expect that, at the end of the funded period, we will refine physical and biodosimetric markers for victims and, importantly, mitigating agents. Our projects' hypotheses are supported by substantial preliminary data, giving us a high expectation of success in the challenging search for countermeasures. The Center wil also grow through training and mentoring activities. Projects 1 and 2 deal with exposure types (inhalation vs. external low/high LET) and mitigation agents in solid organs, with emphasis on lung, bowel, and cutaneous soft tissues. We have preliminary data on several mitigating agents, including long-term data in mice and positive clinical trials in cancer patients. Project 3 features a technology that uses the spin traps in the carbonate of tooth enamel (or bone) and in sulfate of hair and nails, much in the same way as film dosimetry uses silver nitrate. The trapped spins in dental carbonate are permanent and are measured by in vivo non-invasive electron spin resonance. Projects 4 and 5 feature dosimetry and genotoxicity to the whole body (using an immediate readout on reticulocyte micronuclei) and cutaneous tissues (using keratinocyte micronucei and DNA strand break complex detection). A marrow bioreactor that can powerfully test agents and marrow cell subpopulations will also be used with low and high LET. Project 6 investigates a new cancer therapy that produces localized damage, offering the opportunity for quantitative analysis of lung radiosensitivity and thus a means to test mitigating agents in a human model. Biostatistics Core will assist with experimental design/data analysis in all projects and provide advanced analysis to identify significant markers and make treatment recommendations that integrate the host susceptibility measurements (Projects 1, 2) with physical dose (Project 3) and genotoxicity (Projects 4, 5).
期刊论文(61)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ijrobp.2006.01.031
发表时间: 2006-07
期刊: International journal of radiation oncology, biology, physics
影响因子: --
作者: [Zhenyu Xiao;Ying Su;Shanmin Yang;Liangjie Yin;Wei Wang;Y. Yi;B. Fenton;Lurong Zhang;P. Okunieff]
通讯作者: Zhenyu Xiao;Ying Su;Shanmin Yang;Liangjie Yin;Wei Wang;Y. Yi;B. Fenton;Lurong Zhang;P. Okunieff
DOI: 10.1259/bjr/49886569
发表时间: 2010-08
期刊: The British journal of radiology
影响因子: --
作者: [L. Zhang;M. Zhang;S. Yang;Y. Cao;S. Bingrong Zhang;L. Yin;Y. Tian;Y. Ma;A. Zhang;P. Okunieff;L. Zhang]
通讯作者: L. Zhang;M. Zhang;S. Yang;Y. Cao;S. Bingrong Zhang;L. Yin;Y. Tian;Y. Ma;A. Zhang;P. Okunieff;L. Zhang
Long-term immunologically competent human peripheral lymphoid tissue cultures in a 3D bioreactor.
在 3D 生物反应器中长期培养具有免疫活性的人外周淋巴组织。
DOI: 10.1002/bit.23055
发表时间: 2011
期刊: Biotechnology and bioengineering
影响因子: 3.8
作者: [Kuzin,Igor, Sun,Hongliang, Moshkani,Safiekhatoon, Feng,Changyong, Mantalaris,Athanasios, Wu,JHDavid, Bottaro,Andrea]
通讯作者: Bottaro,Andrea
DOI: 10.1007/978-1-4614-4989-8_52
发表时间: 2013
期刊: Advances in experimental medicine and biology
影响因子: --
作者: [Zhang,Mei, Zhang,Bingrong, Guo,Yansong, Zhang,Lei, Yang,Shanmin, Yin,Liangjie, Vidyasagar,Sadasivan, Maguire,David, Swarts,Steve, Zhang,Zhenhuan, Zhang,Amy, Zhang,Lurong, Okunieff,Paul]
通讯作者: Okunieff,Paul
30
    FGF-2 mimetic peptides as pleuripotent mitigators of ARS and DEARE
    • 批准号:
      10845828
    • 项目类别:
    • 资助金额:
      $24.31万
    • 财政年份:
      2020
    • 负责人:
      PAUL OKUNIEFF
    • 依托单位:
    FGF-2 mimetic peptides as pleuripotent mitigators of ARS and DEARE
    • 批准号:
      10401462
    • 项目类别:
    • 资助金额:
      $29.61万
    • 财政年份:
      2020
    • 负责人:
      PAUL OKUNIEFF
    • 依托单位:
    FGF-2 mimetic peptides as pleuripotent mitigators of ARS and DEARE
    • 批准号:
      10194369
    • 项目类别:
    • 资助金额:
      $26.78万
    • 财政年份:
      2020
    • 负责人:
      PAUL OKUNIEFF
    • 依托单位:
    Tissue Modeling & Drug Development Shared Resources Core
    • 批准号:
      10762125
    • 项目类别:
    • 资助金额:
      $16.09万
    • 财政年份:
      2018
    • 负责人:
      PAUL OKUNIEFF
    • 依托单位:
    海外基金